pifithrin has been researched along with trichostatin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chie, EK; Ha, SW; Kao, GD; Kim, IA; Kim, IH; Kim, JH; Kim, JS; Park, CI; Shin, JH; Wu, HG | 1 |
Carlisi, D; D'Anneo, A; Di Fazio, P; Di Leonardo, E; Emanuele, S; Lauricella, M; Tesoriere, G; Vassallo, B; Vento, R | 1 |
2 other study(ies) available for pifithrin and trichostatin a
Article | Year |
---|---|
Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.
Topics: Amides; Benzothiazoles; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Fatty Acids, Unsaturated; Gene Expression Regulation; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Naphthalenes; Pyrones; Radiation-Sensitizing Agents; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2006 |
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; Benzothiazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Liver Neoplasms; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Toluene; Tumor Suppressor Protein p53; Vorinostat | 2008 |